金域医学 (603882.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(金域医学)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 2,001,110,411.402,190,945,442.882,117,566,265.143,268,161,494.383,895,446,380.914,061,112,063.004,251,354,599.88
 营业收入(元) 2,001,110,411.402,190,945,442.882,117,566,265.143,268,161,494.383,895,446,380.914,061,112,063.004,251,354,599.88
二、营业总成本(元) 1,899,083,333.761,855,157,863.051,821,458,551.682,852,741,198.642,895,083,513.283,060,663,468.433,133,771,799.14
 营业成本(元) 1,309,335,078.741,323,258,035.731,314,646,539.732,065,202,985.842,137,572,691.472,315,942,275.822,282,857,543.50
 研发费用(元) 111,258,313.12122,564,536.06131,642,934.47175,364,678.91153,447,497.70161,700,365.44142,105,900.23
 营业税金及附加(元) 3,804,803.233,308,660.213,599,603.274,080,127.443,883,559.393,321,595.643,465,723.29
 销售费用(元) 254,075,118.88250,186,920.28233,482,848.88380,393,352.79361,970,264.21344,843,587.78423,144,466.30
 管理费用(元) 219,960,879.67157,184,383.31138,534,152.93239,442,771.39238,909,873.97238,791,177.14278,387,201.48
 财务费用(元) 649,140.12-1,344,672.54-447,527.60-11,742,717.73-700,373.46-3,935,533.393,810,964.34
  其中:利息费用(元) 4,414,367.575,450,043.395,423,305.346,417,817.635,738,410.065,809,320.785,687,025.18
  其中:利息收入(元) 4,408,023.987,762,452.277,634,261.577,250,593.987,349,297.868,207,236.427,588,184.93
 资产减值损失(元) 255,689.39278,073.5112,793.26989,565.89-413,470.9746,113.56-389,994.11
 信用减值损失(元) -74,836,369.69-169,727,638.43-147,733,754.71-84,552,248.00-64,525,903.22-52,417,511.15-54,635,473.45
三、其他经营收益
 加:投资收益(元) 269,281,171.46-2,513,709.05-4,612,633.19-3,830,307.82-4,139,912.21-2,451,057.12-378,264.56
  其中:对联营企业和合营企业的投资收益(元) -2,655,905.18-2,513,709.05-4,612,633.19-3,830,307.83-4,139,912.24-2,581,752.26-2,655,564.51
 资产处置收益(元) 524,697.6481,042.52-6,570.881,878,758.121,408,383.06186.91705,648.52
 其他收益(元) 8,857,864.087,958,956.1120,673,152.8618,259,308.0113,291,044.7332,325,762.4212,249,162.29
四、营业利润(元) 306,110,130.52171,864,304.49164,440,700.80348,165,371.94945,983,009.02977,952,089.191,075,133,879.43
 加:营业外收入(元) 874,026.311,226,030.59613,127.15188,659.55-45,807.811,002,368.04959,691.90
 减:营业外支出(元) 5,749,494.434,428,768.647,786,282.444,816,359.2721,504,123.771,879,879.17409,188.00
五、利润总额(元) 301,234,662.40168,661,566.44157,267,545.51343,537,672.22924,433,077.44977,074,578.061,075,684,383.33
 减:所得税费用(元) 16,820,572.2427,042,945.7616,650,567.2635,708,381.34122,663,509.23153,112,952.05166,260,989.04
六、净利润(元) 284,414,090.16141,618,620.68140,616,978.25307,829,290.88801,769,568.21823,961,626.01909,423,394.29
(一)按经营持续性分类
  持续经营净利润(元) 284,414,090.16141,618,620.68140,616,978.25307,829,290.88801,769,568.21823,961,626.01909,423,394.29
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 291,173,710.58135,230,269.25149,613,208.46304,441,985.28805,374,277.38792,795,199.63850,173,750.80
  少数股东损益(元) -6,759,620.426,388,351.43-8,996,230.213,387,305.60-3,604,709.1731,166,426.3859,249,643.49
 扣除非经常性损益后的净利润(元) 69,985,996.77131,970,736.66140,603,895.60291,326,256.61808,861,724.50767,824,838.02836,913,620.18
七、每股收益
 一、基本每股收益(元) 0.620.290.320.651.721.701.83
 二、稀释每股收益(元) 0.620.290.320.651.731.691.82
八、其他综合收益(元) 1,969,452.2128,143,198.14-14,870,468.81-22,319,631.3829,684,436.2323,468,251.35-1,027,235.00
 归属于母公司股东的其他综合收益(元) 1,969,452.2128,143,198.14-14,870,468.81-22,319,631.3829,684,436.2323,468,251.35-1,027,235.00
九、综合收益总额(元) 286,383,542.37169,761,818.82125,746,509.44285,509,659.50831,454,004.44847,429,877.36908,396,159.29
 归属于母公司所有者的综合收益总额(元) 293,143,162.79163,373,467.39134,742,739.65282,122,353.90835,058,713.61816,263,450.98849,146,515.80
 归属于少数股东的综合收益总额(元) -6,759,620.426,388,351.43-8,996,230.213,387,305.60-3,604,709.1731,166,426.3859,249,643.49
公告日期 2023-10-282023-08-292023-04-252023-04-252022-10-282022-08-182022-04-27
审计意见(境内) 标准无保留意见

前瞻产业研究院